[Ip-health] PhRMA Statement on HHS Speech and Part B Proposal

James Love james.love at keionline.org
Fri Oct 26 04:54:22 PDT 2018

And this was PhRMA.  Jamie


PhRMA Statement on HHS Speech and Part B Proposal

WASHINGTON, D.C. (October 25, 2018) – Pharmaceutical Research and
Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued
the following statement:

“The administration is imposing foreign price controls from countries with
socialized health care systems that deny their citizens access and
discourage innovation. These proposals are to the detriment of American
patients. The United States has a competitive marketplace that controls
costs and provides patients with access to innovative medicines far earlier
than in countries with price controls, and it’s why we lead the world in
drug discovery and development. Americans have access to cancer medicines
on average about two years earlier than in developed countries like in the
United Kingdom, Germany and France.

“The proposed Medicare Part B model would jeopardize access to medicines
for seniors and patients with disabilities living with devastating
conditions such as cancer, rheumatoid arthritis and other autoimmune
diseases. The administration’s proposal will also hinder patient access by
severely altering the market-based Medicare Part B program by reducing
physician reimbursement and inserting middlemen between patients and their

“We oppose changes to Medicare that threaten patient access to innovative,
lifesaving medicines and are disappointed the administration put the needs
of patients aside with these proposals.”

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents
the country’s leading innovative biopharmaceutical research companies,
which are devoted to discovering and developing medicines that enable
patients to live longer, healthier, and more productive lives. Since 2000,
PhRMA member companies have invested more than $600 billion in the search
for new treatments and cures, including an estimated $71.4 billion in 2017

Connect with PhRMA
For information on how innovative medicines save lives, please visit:

James Love.  Knowledge Ecology International
http://www.keionline.org <http://www.keionline.org/donate.html>

More information about the Ip-health mailing list